메뉴 건너뛰기
Current Medical Research and Opinion
Volumn 23, Issue 10, 2007, Pages 2577-2583
Injection therapy for the treatment of erectile dysfunction: A comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate
Author keywords

Alprostadil; Erectile dysfunction; Intracavernosal injection; Phentolamine; Vasoactive intestinal polypeptide
Indexed keywords

PHENTOLAMINE MESYLATE; PROSTAGLANDIN E1; VASOACTIVE INTESTINAL POLYPEPTIDE;
EID: 35648997466     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X233232     Document Type: Article
Times cited : (21)
References (11)
  • 1
    • 33644937450 scopus 로고    scopus 로고
    • Treating erectile dysfunction when PDE5 inhibitors fail
    • McMahon CN, Smith CJ, Shabsigh R. Treating erectile dysfunction when PDE5 inhibitors fail. BMJ 2006;332: 589-92
    • (2006) BMJ , vol.332 , pp. 589-592
    • McMahon, C.N.1    Smith, C.J.2    Shabsigh, R.3
  • 2
    • 0033780351 scopus 로고    scopus 로고
    • Current perspectives on intracavernosal pharmacotherapy for erectile dysfunction
    • Porst H. Current perspectives on intracavernosal pharmacotherapy for erectile dysfunction. Int J Impot Res 2000;12(Suppl 4): S91-100
    • (2000) Int J Impot Res , vol.12 , Issue.SUPPL. 4
    • Porst, H.1
  • 3
    • 35648956165 scopus 로고    scopus 로고
    • Erectile dysfunction
    • Webber R. Erectile dysfunction. Clin Evid Concise 2005;14: 295-6
    • (2005) Clin Evid Concise , vol.14 , pp. 295-296
    • Webber, R.1
  • 4
    • 0031439935 scopus 로고    scopus 로고
    • Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil - a comparative study in 103 patients with erectile dysfunction
    • Porst H. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil - a comparative study in 103 patients with erectile dysfunction. Int J Impot Res 1997;9:187-92
    • (1997) Int J Impot Res , vol.9 , pp. 187-192
    • Porst, H.1
  • 5
    • 0029919229 scopus 로고    scopus 로고
    • Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
    • Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Eng J Med 1996;334:873-7
    • (1996) N Eng J Med , vol.334 , pp. 873-877
    • Linet, O.I.1    Ogrinc, F.G.2
  • 7
    • 0025220461 scopus 로고
    • Content and distribution of vasoactive intestinal polypeptide (VIP) in cavernous tissue of human penis
    • Shirai M, Maki A, Takanami M, et al. Content and distribution of vasoactive intestinal polypeptide (VIP) in cavernous tissue of human penis. Urology 1990;35:360-3
    • (1990) Urology , vol.35 , pp. 360-363
    • Shirai, M.1    Maki, A.2    Takanami, M.3
  • 8
    • 52649104232 scopus 로고    scopus 로고
    • Potentiation of VIP induced relaxation by phentolamine in corpus cavernosum
    • Kim NN, Gallanc C, Dhir V. Potentiation of VIP induced relaxation by phentolamine in corpus cavernosum. Int J Impot Res 1998;10:S44
    • (1998) Int J Impot Res , vol.10
    • Kim, N.N.1    Gallanc, C.2    Dhir, V.3
  • 9
    • 0033042074 scopus 로고    scopus 로고
    • A double blind placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phentolamine mesilate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction
    • Sandhu D, Curless E, Dean J, et al. A double blind placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phentolamine mesilate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction. Int J Impot Res 1999;11:91-7
    • (1999) Int J Impot Res , vol.11 , pp. 91-97
    • Sandhu, D.1    Curless, E.2    Dean, J.3
  • 10
    • 0032992621 scopus 로고    scopus 로고
    • Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesilate in a novel auto-injector system: A multi-centre double blind placebo controlled study
    • Dinsmore WW, Gingell C, Hackett G, et al. Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesilate in a novel auto-injector system: a multi-centre double blind placebo controlled study. BJU Int 1999;83:274-9
    • (1999) BJU Int , vol.83 , pp. 274-279
    • Dinsmore, W.W.1    Gingell, C.2    Hackett, G.3
  • 11
    • 0031871350 scopus 로고    scopus 로고
    • Vasoactive intestinal polypeptide and phentolamine mesilate in the treatment of patients with erectile dysfunction resistant to other intracavernosal agents
    • Dinsmore WW, Alderdice DK. Vasoactive intestinal polypeptide and phentolamine mesilate in the treatment of patients with erectile dysfunction resistant to other intracavernosal agents. Br J Urol 1998;81:437-4
    • (1998) Br J Urol , vol.81 , pp. 437-434
    • Dinsmore, W.W.1    Alderdice, D.K.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.